The company said EQT and CVC Capital Partners indicated they did not intend to proceed with a $45-per-share bid, and that it was confident in its strategy.
Shares edge up at the closing bell; Westpac results narrowly beat expectations; Healthscope pays all deferred rent to HealthCo REIT; DroneShield wins $25 million contract. Follow live.
Shares fall flat; Origin’s revenue drops; Mayne Pharma shares decline as investors bet on its takeover deal being dead; Steadfast plunges after its CEO stood aside pending an investigation. Follow live.
Shares reset record high; BHP confident of iron ore demand; US-Australia set to pump billions into critical mineral projects; Hub24’s latest trading update impresses investors.
The two-year-old firm is backed by some of the country’s wealthiest families and has been growing its assets under management with a $500 million target.
Both of the $1.2 billion Sydney-based short seller’s funds underperformed the market last month, despite successful short positions in Reece and James Hardie.
Shares open higher; Sigma Healthcare shares rally CSL to invest $760 million in VarmX; Super Retail shares drop after firing CEO over undeclared office romance; BHP up; gold resets record. Follow live.
Shares advance; Sigma Healthcare shares rally after announcing new CFO; CSL to invest $760 million in VarmX; Super Retail shares drop after firing CEO over undeclared office romance; BHP up; gold resets record. Follow live.
Shares rise; CSL to invest $760 million in VarmX; Super Retail shares slump after firing CEO over undeclared office romance; gold resets record. Follow live.
After the most volatile results period on record for the ASX, here’s what fund managers from Airlie to Wilson Asset Management bought and sold last month.
CSL faces an uphill battle to convince investors that its biggest restructure in decades will insulate the global healthcare giant from tough competition and US President Donald Trump’s tariff war.
Several of Regal’s long short strategies benefited off the strong share price rally seen in the defence stock, which has soared almost 430 per cent this year.